首页> 外文期刊>Tissue engineering >Tissue-Engineered Human Vascular Media Produced in Vitro by the Self-Assembly Approach Present Functional Properties Similar to Those of Their Native Blood Vessels
【24h】

Tissue-Engineered Human Vascular Media Produced in Vitro by the Self-Assembly Approach Present Functional Properties Similar to Those of Their Native Blood Vessels

机译:通过自组装方法体外生产的组织工程化人类血管介质的功能特性与其原生血管相似

获取原文
获取原文并翻译 | 示例
           

摘要

We have developed a tissue-engineering approach for the production of a completely biological blood vessel from cultured human cells. In the present study, we took advantage of this tissue-engineering method to demonstrate that it can be used to reproduce the subtle differences in the expression of receptors present on the media of native human blood vessels. Indeed, a small percentage (3 of 18) of native human umbilical cord veins (HUCVs) responded to endothelin, the most powerful vasopressor agent known to date, via both endothelin A (ET_A) and endothelin B (ET_B) receptor activation. In contrast, most HUCVs tested responded to ET via ET_A receptor activation only. Tissue-engineered vascular media (TEVM) were next reconstructed by using vascular smooth muscle cells (VSMCs) isolated and cultured from HUCVs expressing both ET_A and ET_B receptors to determine the functional integrity of our TEVM model. The reconstructed TEVM presents an endothelin response similar to that of respective HUCVs from which VSMCs were isolated. Reverse transcriptase polymerase chain reaction on TEVM reconstructed in vitro correlated these vaso-contractile profiles by showing the presence of messenger RNA for both ET_A and ET_B receptors. Taken together with recently published results on TEVM expressing only ET_A receptor, these results show that our reconstructed TEVM present a similar ET response profile as the blood vessel from which the VSMCs were isolated and cultured. These findings indicate that subtle differences, such as receptor expression, are preserved in the reconstructed tissue. Therefore, our TEVM offers a valuable human in vitro model with which to study the functionality of human blood vessels, such as their vasoactive response, or to perform pharmacologic studies.
机译:我们已经开发出一种组织工程方法,可以从培养的人类细胞生产出完全生物的血管。在本研究中,我们利用这种组织工程方法来证明它可用于重现天然人血管介质中存在的受体表达的细微差异。实际上,一小部分(18个中的3个)天然人脐带静脉(HUCV)通过内皮素A(ET_A)和内皮素B(ET_B)受体激活对内皮素(迄今已知的最强大的血管升压药)产生反应。相反,大多数测试的HUCV仅通过ET_A受体激活对ET做出反应。接下来,通过使用从表达ET_A和ET_B受体的HUCV中分离并培养的血管平滑肌细胞(VSMC),重建组织工程化的血管介质(TEVM),以确定我们的TEVM模型的功能完整性。重建的TEVM的内皮素反应类似于从中分离VSMC的各个HUCV的反应。体外重建的TEVM上的逆转录酶聚合酶链反应通过显示ET_A和ET_B受体的信使RNA的存在使这些血管收缩特征相关。结合最近发表的仅表达ET_A受体的TEVM结果,这些结果表明,我们重建的TEVM与分离和培养VSMC的血管具有相似的ET反应谱。这些发现表明在重建的组织中保留了细微的差异,例如受体表达。因此,我们的TEVM提供了一种有价值的人体体外模型,可用于研究人体血管的功能,例如其血管活性反应或进行药理研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号